Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-30
2006-05-30
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S295000
Reexamination Certificate
active
07053118
ABSTRACT:
The subject invention provides novel compositions of biologically active compounds which can advantageously be used for inhibiting pathological cellular proliferation. The compounds of the subject invention have utility for use in the treatment of cancer, including tumors.
REFERENCES:
patent: 4206221 (1980-06-01), Miller et al.
patent: 4548814 (1985-10-01), Rinehart, Jr. et al.
patent: 4729996 (1988-03-01), Wright et al.
patent: 4737510 (1988-04-01), Rinehart, Jr. et al.
patent: 4808590 (1989-02-01), Higa et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 5157049 (1992-10-01), Haugwitz et al.
patent: 5789605 (1998-08-01), Smith et al.
patent: WO 9824429 (1998-06-01), None
Faulkner, D.J. “Marine Natural Products”Natural Products Reports1998, vol. 15, pp. 113-158.
Fuchs, D.A. Johnson, R.K. “Cytologic evidence that taxol, an antineoplastic agent fromTaxus brevifolia, acts as a mitotic spindle poison”Cancer Treat. Rep.1978, vol. 62, pp. 1219-1222.
Gunasekera, S.P. et al. “Discodermolide: A new bioactive polyhydroxy lactone from the marine spongeDiscodermia dissolute” J. Org. Chem.1990, vol. 55, pp. 4912-4915 [correctionJ. Org. Chem.1991, vol. 56, p. 1346.]
Kowalski et al. “The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells”Mol. Pharmacol.1997, vol. 52, pp. 613-622.
Minale, L. et al. “Natural products from porifera”Fortschr. Chem. Org. Naturst.1976, vol. 33, pp. 1-72.
Rowinski, E.K., Donehower, R.C. “Paclitaxel (Taxol)”N. Engl. J. Med.1995, vol. 332, pp. 1004-1014.
Scheuer, P.J. (ed.)Marine Natural Products, Chemical and Biological Perspectives, Academic Press, New York, 1978-1983, vol. I-V.
Schiff, P.B et al. “Promotion of microtubule assembly in vitro by taxol”Nature1979, vol. 22, pp. 665-667.
Ter Haar et al. “Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol”Biochemistry1996, vol. 35, pp. 243-250.
Uemura, D. et al. “Norhalichondrin A: An Antitumor Polyether Macrolide from a Marine Sponge”J. Am. Chem. Soc.1985, vol. 107, pp. 4796-4798.
Gunasekera Sarath P.
Longley Ross E.
Reed John K.
Wright Amy E.
Chong Yong S.
Harbor Branch Oceanographic Institution Inc.
Saliwanchik Lloyd & Saliwanchik
Wang Shengjun
LandOfFree
Lactone compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactone compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactone compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578081